BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 12630676)

  • 1. A novel substance purified from Perilla frutescens Britton inhibits an early stage of HIV-1 replication without blocking viral adsorption.
    Kawahata T; Otake T; Mori H; Kojima Y; Oishi I; Oka S; Fukumori Y; Sano K
    Antivir Chem Chemother; 2002 Sep; 13(5):283-8. PubMed ID: 12630676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyanionic (i.e., polysulfonate) dendrimers can inhibit the replication of human immunodeficiency virus by interfering with both virus adsorption and later steps (reverse transcriptase/integrase) in the virus replicative cycle.
    Witvrouw M; Fikkert V; Pluymers W; Matthews B; Mardel K; Schols D; Raff J; Debyser Z; De Clercq E; Holan G; Pannecouque C
    Mol Pharmacol; 2000 Nov; 58(5):1100-8. PubMed ID: 11040059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of HIV-2(ROD) replication in a lymphoblastoid cell line by the alpha1-antitrypsin Portland variant (alpha1-PDX) and the decRVKRcmk peptide: comparison with HIV-1(LAI).
    Bahbouhi B; Bendjennat M; Chiva C; Kogan M; Albericio F; Giralt E; Seidah NG; Bahraoui E
    Microbes Infect; 2001 Nov; 3(13):1073-84. PubMed ID: 11709287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of human immunodeficiency virus replication by RD6-Y664, a novel benzylhydroxylamine derivative.
    Okamoto M; Fujiwara M; Kodama E; Yamamoto O; Shigeta S; Mitsuya H; Konno K; Yokota T; Baba M
    Antivir Chem Chemother; 1999 Mar; 10(2):71-7. PubMed ID: 10335401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative in vitro effects of AZT and extracts of Ocimum gratissimum, Ficus polita, Clausena anisata, Alchornea cordifolia, and Elaeophorbia drupifera against HIV-1 and HIV-2 infections.
    Ayisi NK; Nyadedzor C
    Antiviral Res; 2003 Mar; 58(1):25-33. PubMed ID: 12719004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of anti-human immunodeficiency virus action of polyoxometalates, a class of broad-spectrum antiviral agents.
    Yamamoto N; Schols D; De Clercq E; Debyser Z; Pauwels R; Balzarini J; Nakashima H; Baba M; Hosoya M; Snoeck R
    Mol Pharmacol; 1992 Dec; 42(6):1109-17. PubMed ID: 1282664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and characterization of niphatevirin, a human-immunodeficiency-virus-inhibitory glycoprotein from the marine sponge Niphates erecta.
    O'Keefe BR; Beutler JA; Cardellina JH; Gulakowski RJ; Krepps BL; McMahon JB; Sowder RC; Henderson LE; Pannell LK; Pomponi SA; Boyd MR
    Eur J Biochem; 1997 Apr; 245(1):47-53. PubMed ID: 9128723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isothiazole derivatives as novel HIV replication inhibitors.
    Cutrì CC; Garozzo A; Pannecouque C; Castro A; Guerrera F; De Clercq E
    Antivir Chem Chemother; 2004 Jul; 15(4):201-5. PubMed ID: 15457681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New targets for inhibitors of HIV-1 replication.
    Moore JP; Stevenson M
    Nat Rev Mol Cell Biol; 2000 Oct; 1(1):40-9. PubMed ID: 11413488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro evaluation and characterization of newly designed alkylamidophospholipid analogues as anti-human immunodeficiency virus type 1 agents.
    Kucera LS; Iyer N; Morris-Natschke SL; Chen SY; Gumus F; Ishaq K; Herrmann DB
    Antivir Chem Chemother; 1998 Mar; 9(2):157-65. PubMed ID: 9875387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly potent inhibition of human immunodeficiency virus type 1 replication by TAK-220, an orally bioavailable small-molecule CCR5 antagonist.
    Takashima K; Miyake H; Kanzaki N; Tagawa Y; Wang X; Sugihara Y; Iizawa Y; Baba M
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3474-82. PubMed ID: 16048963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral activity of diterpenes isolated from the Brazilian marine alga Dictyota menstrualis against human immunodeficiency virus type 1 (HIV-1).
    Pereira HS; Leão-Ferreira LR; Moussatché N; Teixeira VL; Cavalcanti DN; Costa LJ; Diaz R; Frugulhetti IC
    Antiviral Res; 2004 Oct; 64(1):69-76. PubMed ID: 15451181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substance P antagonist (CP-96,345) inhibits HIV-1 replication in human mononuclear phagocytes.
    Lai JP; Ho WZ; Zhan GX; Yi Y; Collman RG; Douglas SD
    Proc Natl Acad Sci U S A; 2001 Mar; 98(7):3970-5. PubMed ID: 11274418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent, broad-spectrum inhibition of human immunodeficiency virus type 1 by the CCR5 monoclonal antibody PRO 140.
    Trkola A; Ketas TJ; Nagashima KA; Zhao L; Cilliers T; Morris L; Moore JP; Maddon PJ; Olson WC
    J Virol; 2001 Jan; 75(2):579-88. PubMed ID: 11134270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of human immunodeficiency virus replication by a dual CCR5/CXCR4 antagonist.
    Princen K; Hatse S; Vermeire K; Aquaro S; De Clercq E; Gerlach LO; Rosenkilde M; Schwartz TW; Skerlj R; Bridger G; Schols D
    J Virol; 2004 Dec; 78(23):12996-3006. PubMed ID: 15542651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxysterols, but not cholesterol, inhibit human immunodeficiency virus replication in vitro.
    Moog C; Aubertin AM; Kirn A; Luu B
    Antivir Chem Chemother; 1998 Nov; 9(6):491-6. PubMed ID: 9865387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanistic effect of NMSO3 on replication of human immunodeficiency virus.
    Nakamura M; Terada M; Kamada M; Yokono A; Nakamori S; Ohno T
    Antivir Chem Chemother; 2003 Jul; 14(4):171-6. PubMed ID: 14582845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New anti-HIV agents and targets.
    De Clercq E
    Med Res Rev; 2002 Nov; 22(6):531-65. PubMed ID: 12369088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitro.
    Svicher V; Balestra E; Cento V; Sarmati L; Dori L; Vandenbroucke I; D'Arrigo R; Buonomini AR; Van Marck H; Surdo M; Saccomandi P; Mostmans W; Aerssens J; Aquaro S; Stuyver LJ; Andreoni M; Ceccherini-Silberstein F; Perno CF
    Antiviral Res; 2011 Apr; 90(1):42-53. PubMed ID: 21349294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Debio-025 inhibits HIV-1 by interfering with an early event in the replication cycle.
    Daelemans D; Dumont JM; Rosenwirth B; De Clercq E; Pannecouque C
    Antiviral Res; 2010 Feb; 85(2):418-21. PubMed ID: 19857522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.